Patent 7781479 was granted and assigned to Dainippon Sumitomo on August, 2010 by the United States Patent and Trademark Office.
A compound of the following formula (1), or its prodrug or pharmaceutically acceptable salt thereof, being useful as a diabetic medicine or preventive, or blood sugar regulator, or therapeutic agent for hyperlipemia, etc.